Page last updated: 2024-10-26

dipyridamole and Age-Related Macular Degeneration

dipyridamole has been researched along with Age-Related Macular Degeneration in 1 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Research Excerpts

ExcerptRelevanceReference
"Age related macular degeneration is the leading cause of blindness in the developed world."1.46AICAR suppresses TNF-α-induced complement factor B in RPE cells. ( Chung, EJ; Efstathiou, NE; Konstantinou, EK; Maidana, DE; Miller, JW; Vavvas, DG; Young, LH, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chung, EJ1
Efstathiou, NE1
Konstantinou, EK1
Maidana, DE1
Miller, JW1
Young, LH1
Vavvas, DG1

Other Studies

1 other study available for dipyridamole and Age-Related Macular Degeneration

ArticleYear
AICAR suppresses TNF-α-induced complement factor B in RPE cells.
    Scientific reports, 2017, 12-15, Volume: 7, Issue:1

    Topics: Aminoimidazole Carboxamide; Cell Line; Clustered Regularly Interspaced Short Palindromic Repeats; Co

2017